Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney

This article is a result of their own long-term observation of the patient treatment of inoperable cancer of the kidney. As first-line therapy pazopanib is used in standard dosage. The drug belongs to the new generation of drugs that block angiogenesis and having cytoreductive effect. During treatme...

Full description

Bibliographic Details
Main Authors:	A A Klimenko, S A Ivanov
Format:	Article
Language:	Russian
Published:	IP Habib O.N. 2013-12-01
Series:	Современная онкология
Subjects:	renal cell cancer angiogenesis targeted therapy
Online Access:	https://modernonco.orscience.ru/1815-1434/article/view/26927

id	doaj-de54b89183c54d50a98050a5611190ac
record_format	Article
spelling	doaj-de54b89183c54d50a98050a5611190ac2020-11-25T03:32:55ZrusIP Habib O.N.Современная онкология1815-14341815-14422013-12-01154454624147Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidneyA A KlimenkoS A IvanovThis article is a result of their own long-term observation of the patient treatment of inoperable cancer of the kidney. As first-line therapy pazopanib is used in standard dosage. The drug belongs to the new generation of drugs that block angiogenesis and having cytoreductive effect. During treatment, the stabilization of the disease. The results of treatment can be recommended for use pazopanib treatment of kidney cancer.https://modernonco.orscience.ru/1815-1434/article/view/26927renal cell cancerangiogenesistargeted therapy
collection	DOAJ
language	Russian
format	Article
sources	DOAJ
author	A A Klimenko S A Ivanov
spellingShingle	A A Klimenko S A Ivanov Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney Современная онкология renal cell cancer angiogenesis targeted therapy
author_facet	A A Klimenko S A Ivanov
author_sort	A A Klimenko
title	Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
title_short	Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
title_full	Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
title_fullStr	Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
title_full_unstemmed	Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
title_sort	clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
publisher	IP Habib O.N.
series	Современная онкология
issn	1815-1434 1815-1442
publishDate	2013-12-01
description	This article is a result of their own long-term observation of the patient treatment of inoperable cancer of the kidney. As first-line therapy pazopanib is used in standard dosage. The drug belongs to the new generation of drugs that block angiogenesis and having cytoreductive effect. During treatment, the stabilization of the disease. The results of treatment can be recommended for use pazopanib treatment of kidney cancer.
topic	renal cell cancer angiogenesis targeted therapy
url	https://modernonco.orscience.ru/1815-1434/article/view/26927
work_keys_str_mv	AT aaklimenko clinicalexampleofthedrugpazopanibasatargetedtherapyininoperablecancerofthekidney AT saivanov clinicalexampleofthedrugpazopanibasatargetedtherapyininoperablecancerofthekidney
_version_	1724565969544675328

Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney

Similar Items